About this item:

113 Views | 57 Downloads

Author Notes:

Jennifer C. Wong, Email: jennifer.c.wong@emory.edu

JW and AE contributed to the conception and design of the study. JW performed the experiments, statistical analyses, and wrote the first draft of the manuscript. LS and JT performed experiments and statistical analyses. KB, KM, and KG surveyed databases. KG, PG, SK, and BS performed genetic testing and clinical diagnoses. All authors contributed to manuscript revision, read, and approved the submitted version.

The authors would like to thank Dr. Deborah Cook for editorial assistance.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Subjects:

Research Funding:

This project was supported by the National Institutes of Health (JCW, R21NS114795; AE R03NS114791). The content is solely the author’s responsibility and does not necessarily reflect the official view of the National Institutes of Health. The authors have no financial interests related to this work and declare no competing interests.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Pharmacology & Pharmacy
  • SCN8A
  • sodium channel
  • epilepsy
  • seizure
  • mouse
  • mutation
  • SODIUM-CHANNEL SCN8A
  • DE-NOVO
  • EPILEPTIC ENCEPHALOPATHY
  • BINDING MOTIF
  • MUTATIONS
  • NA(V)1.6
  • SEIZURE
  • FAMILY
  • SCN1A
  • ACTIVATION

Pathogenic in-Frame Variants in SCN8A: Expanding the Genetic Landscape of SCN8A-Associated Disease

Tools:

Journal Title:

FRONTIERS IN PHARMACOLOGY

Volume:

Volume 12

Publisher:

, Pages 748415-748415

Type of Work:

Article | Final Publisher PDF

Abstract:

Numerous SCN8A mutations have been identified, of which, the majority are de novo missense variants. Most mutations result in epileptic encephalopathy; however, some are associated with less severe phenotypes. Mouse models generated by knock-in of human missense SCN8A mutations exhibit seizures and a range of behavioral abnormalities. To date, there are only a few Scn8a mouse models with in-frame deletions or insertions, and notably, none of these mouse lines exhibit increased seizure susceptibility. In the current study, we report the generation and characterization of two Scn8a mouse models (ΔIRL/+ and ΔVIR/+) carrying overlapping in-frame deletions within the voltage sensor of domain 4 (DIVS4). Both mouse lines show increased seizure susceptibility and infrequent spontaneous seizures. We also describe two unrelated patients with the same in-frame SCN8A deletion in the DIV S5-S6 pore region, highlighting the clinical relevance of this class of mutations.

Copyright information:

© 2021 Wong, Butler, Shapiro, Thelin, Mattison, Garber, Goldenberg, Kubendran, Schaefer and Escayg.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/rdf).
Export to EndNote